ArticleJTO clinical and research reports2020

Hypercalcemia as a Rebound Phenomenon of LOXO-292 Efficacy in Medullary Thyroid Cancer.

Waleed Kian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.